Showing results (1721-1730 of 1,786) with videos related to

Sort By:
Pageof 179
Transplantation|September 15, 1996
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study GroupE S Woodle, J R Thistlethwaite, J H Gordon, et al.
Nature Materials|March 25, 2025
Tension anisotropy drives fibroblast phenotypic transition by self-reinforcing cell-extracellular matrix mechanical feedbackFarid Alisafaei, Delaram Shakiba, Yuan Hong, et al.
Cell|April 21, 2018
Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like DomainsLin Guo, Hong Joo Kim, Hejia Wang, et al.
Contemporary Clinical Trials|August 10, 2021
Multilevel Follow-up of Cancer Screening (mFOCUS): Protocol for a multilevel intervention to improve the follow-up of abnormal cancer screening test resultsJennifer S Haas, Steven J Atlas, Adam Wright, et al.
The Lancet. Neurology|December 15, 2023
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trialAndrew McGarry, Shane Rosanbalm, Mika Leinonen, et al.
Neuron|December 27, 2011
High frequencies of de novo CNVs in bipolar disorder and schizophreniaDheeraj Malhotra, Shane McCarthy, Jacob J Michaelson, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 InhibitorBryan K Chan, Anthony A Estrada, Huifen Chen, et al.
Molecular Cancer Research : MCR|February 13, 2018
Antisecretory Factor-Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in GlioblastomaShirin Ilkhanizadeh, Hanna Sabelström, Yekaterina A Miroshnikova, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2011
Mutation of the conserved polyadenosine RNA binding protein, ZC3H14/dNab2, impairs neural function in Drosophila and humansChanghui Pak, Masoud Garshasbi, Kimia Kahrizi, et al.
Journal of Medicinal Chemistry|July 18, 2008
A pentacyclic aurora kinase inhibitor (AKI-001) with high in vivo potency and oral bioavailabilityThomas E Rawson, Matthias Rüth, Elizabeth Blackwood, et al.
Pageof 179